Patents Assigned to DiFusion, Inc.
  • Patent number: 12178936
    Abstract: Anti-biofilm osseointegrating and/or tissue-integrating implantable biomaterial devices that optionally can elute therapeutic ions such as magnesium, silver, copper and/or zinc. In certain embodiments, the devices are engineered to produce structures suitable as implants having a relatively high surface population of zeolite. Methods of producing the devices are also disclosed.
    Type: Grant
    Filed: September 27, 2023
    Date of Patent: December 31, 2024
    Assignee: DiFusion, Inc.
    Inventors: Derrick Johns, Joseph J. Crudden, Sriram Sankar